Goldman Sachs’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.2M | Buy |
949,980
+330,417
| +53% | +$5.98M | ﹤0.01% | 1877 |
|
|
2025
Q1 | $12.7M | Sell |
619,563
-35,147
| -5% | -$719K | ﹤0.01% | 2049 |
|
|
2024
Q4 | $16.8M | Buy |
654,710
+620,637
| +1,821% | +$16M | ﹤0.01% | 1925 |
|
|
2024
Q3 | $566K | Buy |
34,073
+8,686
| +34% | +$144K | ﹤0.01% | 4049 |
|
|
2024
Q2 | $488K | Sell |
25,387
-1,258,068
| -98% | -$24.2M | ﹤0.01% | 3969 |
|
|
2024
Q1 | $30.4M | Sell |
1,283,455
-100,866
| -7% | -$2.39M | 0.01% | 1275 |
|
|
2023
Q4 | $15.5M | Buy |
+1,384,321
| New | +$15.5M | ﹤0.01% | 1769 |
|